Rigel Pharmaceuticals (RIGL) Change in Inventory (2018 - 2025)
Rigel Pharmaceuticals has reported Change in Inventory over the past 8 years, most recently at -$1.1 million for Q4 2025.
- For Q4 2025, Change in Inventory rose 41.25% year-over-year to -$1.1 million; the TTM value through Dec 2025 reached $5.6 million, up 837.57%, while the annual FY2025 figure was $5.6 million, 837.57% up from the prior year.
- Change in Inventory for Q4 2025 was -$1.1 million at Rigel Pharmaceuticals, down from -$188000.0 in the prior quarter.
- Over five years, Change in Inventory peaked at $8.4 million in Q2 2025 and troughed at -$3.3 million in Q3 2024.
- A 5-year average of $547550.0 and a median of -$151000.0 in 2021 define the central range for Change in Inventory.
- Biggest five-year swings in Change in Inventory: surged 2078.51% in 2021 and later plummeted 1090.04% in 2024.
- Year by year, Change in Inventory stood at -$450000.0 in 2021, then soared by 540.67% to $2.0 million in 2022, then plummeted by 227.63% to -$2.5 million in 2023, then increased by 23.94% to -$1.9 million in 2024, then skyrocketed by 41.25% to -$1.1 million in 2025.
- Business Quant data shows Change in Inventory for RIGL at -$1.1 million in Q4 2025, -$188000.0 in Q3 2025, and $8.4 million in Q2 2025.